Business / Finance

RSS
Revance closes $45 million financing

Revance closes $45 million financing

Ambit Biosciences raises $30 million through Series D-2 equity financing

Ambit Biosciences raises $30 million through Series D-2 equity financing

Centric Health first quarter revenue increases 67% to $23.0 million

Centric Health first quarter revenue increases 67% to $23.0 million

Patheon second quarter revenues decrease 3.1% to $170.0 million

Patheon second quarter revenues decrease 3.1% to $170.0 million

lululemon athletica first quarter net revenue increases 35% to $186.8 million

lululemon athletica first quarter net revenue increases 35% to $186.8 million

Chinese medical devices market to achieve revenues of $30.6B by 2017

Chinese medical devices market to achieve revenues of $30.6B by 2017

Accuray receives shareholders approval to acquire TomoTherapy

Accuray receives shareholders approval to acquire TomoTherapy

ASI announces successful completion of $10 million round of financing

ASI announces successful completion of $10 million round of financing

Birner Dental Management increases quarterly dividend to $.22 per share

Birner Dental Management increases quarterly dividend to $.22 per share

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

PDL revises revenue guidance for second quarter 2011 to $122M

PDL revises revenue guidance for second quarter 2011 to $122M

UAB acquires first cell-processing workstation from SANYO

UAB acquires first cell-processing workstation from SANYO

Blue Shield of California will cap earnings

Blue Shield of California will cap earnings

Brookdale prices 2.75% Convertible Senior Notes due 2018

Brookdale prices 2.75% Convertible Senior Notes due 2018

Isotechnika reports consolidated net loss of $2.9 million for first quarter 2011

Isotechnika reports consolidated net loss of $2.9 million for first quarter 2011

Sandbox announces business accelerator for healthcare industry

Sandbox announces business accelerator for healthcare industry

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market

Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market

Grifols officially merges with Talecris Biotherapeutics

Grifols officially merges with Talecris Biotherapeutics

Amedisys acquires Beacon Hospice

Amedisys acquires Beacon Hospice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.